CN1380092A - 痔愈散 - Google Patents
痔愈散 Download PDFInfo
- Publication number
- CN1380092A CN1380092A CN 02117662 CN02117662A CN1380092A CN 1380092 A CN1380092 A CN 1380092A CN 02117662 CN02117662 CN 02117662 CN 02117662 A CN02117662 A CN 02117662A CN 1380092 A CN1380092 A CN 1380092A
- Authority
- CN
- China
- Prior art keywords
- grams
- hemorrhoid
- powder
- radix
- bletillae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000014617 hemorrhoid Diseases 0.000 title claims abstract description 22
- 239000000843 powder Substances 0.000 title claims abstract description 8
- 239000004863 Frankincense Substances 0.000 claims abstract description 9
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 6
- 239000003814 drug Substances 0.000 claims abstract description 5
- 241000628997 Flos Species 0.000 claims description 16
- 241000717739 Boswellia sacra Species 0.000 claims description 8
- 241000218176 Corydalis Species 0.000 claims description 8
- 241001057584 Myrrha Species 0.000 claims description 8
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 8
- 241000180649 Panax notoginseng Species 0.000 claims description 8
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 208000016583 Anus disease Diseases 0.000 abstract description 10
- 206010002153 Anal fissure Diseases 0.000 abstract description 9
- 208000009531 Fissure in Ano Diseases 0.000 abstract description 9
- 208000004680 Rectal Fistula Diseases 0.000 abstract description 8
- 206010002156 anal fistula Diseases 0.000 abstract description 8
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 2
- 208000026935 allergic disease Diseases 0.000 abstract description 2
- 230000007815 allergy Effects 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241001313857 Bletilla striata Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 235000002566 Capsicum Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 239000006002 Pepper Substances 0.000 abstract 1
- 235000016761 Piper aduncum Nutrition 0.000 abstract 1
- 235000017804 Piper guineense Nutrition 0.000 abstract 1
- 244000203593 Piper nigrum Species 0.000 abstract 1
- 235000008184 Piper nigrum Nutrition 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 244000173853 Sanguisorba officinalis Species 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000010446 mirabilite Substances 0.000 abstract 1
- 230000004044 response Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 208000030090 Acute Disease Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明自拟“痔愈散”属于纯中药制剂,主要治疗外痔、混合痔、肛裂、肛瘘及肛门周围术后等病症。它包括三七、地榆炭、延胡索、金银花、蒲公英、槐花、肉桂、玄参、白芨、乳香、没药、花椒、芒硝、冰片,各组分的重量分别为:1.2~1.8克、4.2~4.8克、4.2~4.8克、6~7.8克、6~7.8克、5.4~6克、4.2~4.8克、4.2~4.8克、3~3.6克、3~3.6克、3~3.6克、3.6~4.2克、2.4~3克、1.2~1.8克。将上药加工制成散剂,它具有疗程短、见效快,无感染不过敏,治愈率高,费用低廉,使用方法简便的优点。
Description
一、技术领域
本发明属于纯中药制剂,主要治疗外痔、混合痔、肛裂、肛瘘及肛门周围术后等病症。
二、背景技术
痔疮在临床上是一种多发病,它是由于气血下陷,肠毒搏结,结聚肛门,宿滞不散,或时常便秘,影响肛门淋巴回流受阻而致。肠热燥结常可引起肛裂。主要由饮食不洁、久痢久泻、怀孕、分娩、便秘等引起。急病发作时肛周疼痛较剧,坐卧不宁,肛裂同时可伴有便血,严重影响人们的生活、工作及学习,其痛苦难以言喻。目前,临床上治疗多以手术、抗菌消炎及对症治疗为主。以1‰高锰酸钾坐浴,疗效并不理想。
三、发明内容
本发明自拟“痔愈散”是这样实现的:它包括三七、地榆炭、延胡索、金银花、蒲公英、槐花、肉桂、玄参、白芨、乳香、没药、花椒、芒硝、冰片,各组分的重量分别为:1.2~1.8克、4.2~4.8克、4.2~4.8克、6~7.8克、6~7.8克、5.4~6克、4.2~4.8克、4.2~4.8克、3~3.6克、3~3.6克、3~3.6克、3.6~4.2克、2.4~3克、1.2~1.8克。
所述的三七、地榆炭、延胡索、金银花、蒲公英、槐花、肉桂、玄参、白芨、乳香、没药和花椒粉碎后的粒度为小于80目。
应用成品中药制剂坐浴是肛肠科中一项空白,本人从事痔瘘治疗工作多年,经过临床研究,从1995年4月-2001年3月,六年间在临床上治疗痔疮、肛裂、肛瘘等术后患者426例,效果显著,无一例不良反应及副作用,总有效率达98.5%以上。其特点总结如下:
1、疗程短、见效快。外痔、肛裂患者三至五天即可痊愈,对痔疮或肛周术后疼痛、创面愈合疗效比较显著。
2、无感染不过敏。无论患者在疾病发作时或痔疮、肛瘘术后用药临床426例痔瘘患者验证无一例感染或过敏等不良反应。
3、治愈率高。经过临床426例痔瘘患者临床观察,有效率达98.5%以上。
4、费用低廉。每个疗程约需19元(为市场零售价)。
5、方法简便。当急病发作(痔疮肿痛或肛裂便血)或肛门周围术后五小时内,用开水溶开本剂即可坐浴。
本发明包括三七、地榆炭、延胡索、金银花、蒲公英、槐花、肉桂、玄参、白芨、乳香、没药、花椒、芒硝、冰片共十四位中药,其中三七、延胡索、乳香活血祛瘀,行气止痛。金银花、蒲公英清热解毒、活血散瘀,且有抑菌作用。地榆炭、白芨、没药对肛裂或痔疮、肛瘘术后久不收口起敛口消肿、生肌、促进伤口愈合之功效。花椒、冰片对肛周局部有麻醉作用,而且防腐止痒。槐花、芒硝对肛裂便血及痔疮肿痛效用十分明显。将所述的三七1.73克、地榆炭4.6克、延胡索4.6克、金银花7.65克、蒲公英7.65克、槐花5.75克、肉桂4.6克、玄参4.6克、白芨3.46克、乳香3.46克、没药3.46克、花椒4.13克粉碎,过80目筛。然后把芒硝2.88克、冰片1.43克加入,混合均匀,总量为60克。后等分成各30克包装。使用时,取30克,置入盆内,用750毫升左右的开水溶开,温度适宜后坐浴25~30分钟。每日两次,每五天为一疗程。
Claims (3)
1、自拟“痔愈散”其特征在于:它包括三七、地榆炭、延胡索、金银花、蒲公英、槐花、肉桂、玄参、白芨、乳香、没药、花椒、芒硝、冰片,十四位中药各组分的重量分别为:1.2~1.8克、4.2~4.8克、4.2~4.8克、6~7.8克、6~7.8克、5.4~6克、4.2~4.8克、4.2~4.8克、3~3.6克、3~3.6克、3~3.6克、3.6~4.2克、2.4~3克、1.2~1.8克。
2、根据权利要求1所述的“痔愈散”,其特征在于:所述的三七、地榆炭、延胡索、金银花、蒲公英、槐花、肉桂、玄参、白芨、乳香、没药和花椒的粒度粉碎后为小于80目,开水溶开,直接坐浴。
3、根据权利要求1所述的“痔愈散”,其特征在于:总量为60克中各组份的重量最佳值分别为:三七1.73克、地榆炭4.6克、延胡索4.6克、金银花7.65克、蒲公英7.65克、槐花5.75克、肉桂4.6克、玄参4.6克、白芨3.46克、乳香3.46克、没药3.46克、花椒4.13克。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021176620A CN1167453C (zh) | 2002-05-14 | 2002-05-14 | 一种治疗痔疮的散剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021176620A CN1167453C (zh) | 2002-05-14 | 2002-05-14 | 一种治疗痔疮的散剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1380092A true CN1380092A (zh) | 2002-11-20 |
CN1167453C CN1167453C (zh) | 2004-09-22 |
Family
ID=4744483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021176620A Expired - Fee Related CN1167453C (zh) | 2002-05-14 | 2002-05-14 | 一种治疗痔疮的散剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1167453C (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102579657A (zh) * | 2012-03-29 | 2012-07-18 | 孙晓霞 | 一种用于治疗痔漏的熏洗剂 |
CN102920877A (zh) * | 2012-11-01 | 2013-02-13 | 黎世云 | 治疗痔疮的中药 |
CN103393942A (zh) * | 2013-08-01 | 2013-11-20 | 刘建飞 | 一种治疗肛裂的中药制剂 |
CN105770448A (zh) * | 2016-04-19 | 2016-07-20 | 成都市新都区中医医院 | 一种防治肛周疾病的药物组合物及其制备方法 |
-
2002
- 2002-05-14 CN CNB021176620A patent/CN1167453C/zh not_active Expired - Fee Related
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102579657A (zh) * | 2012-03-29 | 2012-07-18 | 孙晓霞 | 一种用于治疗痔漏的熏洗剂 |
CN102920877A (zh) * | 2012-11-01 | 2013-02-13 | 黎世云 | 治疗痔疮的中药 |
CN102920877B (zh) * | 2012-11-01 | 2014-04-30 | 黎世云 | 治疗痔疮的中药 |
CN103393942A (zh) * | 2013-08-01 | 2013-11-20 | 刘建飞 | 一种治疗肛裂的中药制剂 |
CN103393942B (zh) * | 2013-08-01 | 2015-04-29 | 刘建飞 | 一种治疗肛裂的中药制剂 |
CN105770448A (zh) * | 2016-04-19 | 2016-07-20 | 成都市新都区中医医院 | 一种防治肛周疾病的药物组合物及其制备方法 |
CN105770448B (zh) * | 2016-04-19 | 2019-10-29 | 成都市新都区中医医院 | 一种防治肛周疾病的药物组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1167453C (zh) | 2004-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100584371C (zh) | 含有硫糖铝治疗胃溃疡的中西药组合物 | |
CN101066434A (zh) | 含有奥美拉唑的药物 | |
CN101066435A (zh) | 含有艾普拉唑的药物 | |
CN103230491A (zh) | 一种治疗痔疮的内服和外用组合苗药及其制备方法 | |
CN1167453C (zh) | 一种治疗痔疮的散剂 | |
CN1319574C (zh) | 一种治疗便秘的药物 | |
CN1742904A (zh) | 一种治疗尿石症和泌尿系感染症的中药及其生产方法 | |
CN100515485C (zh) | 治疗胃溃疡的药物组合物 | |
CN102772695A (zh) | 一种治疗口腔溃疡的含片及其制备方法 | |
CN1255165C (zh) | 治疗内外溃疡的中药制剂及其制备方法 | |
CN101066416A (zh) | 含有雷贝拉唑治疗胃溃疡的药物 | |
CN1278727C (zh) | 一种结肠炎灌肠剂 | |
CN1286515C (zh) | 一种治疗囊肿的药物组合物 | |
CN101926958B (zh) | 一种含有甘珀酸钠的中西药组合物 | |
CN100574793C (zh) | 含有雷尼替丁的药物 | |
CN101066418B (zh) | 含有胶体铋治疗胃溃疡的药物 | |
CN1813876A (zh) | 仙硼疗氟口服制剂 | |
CN1382466A (zh) | 一种整骨药 | |
CN101732663B (zh) | 含有瑞巴派特的中西药组合物 | |
CN101773645B (zh) | 含有螺佐呋酮的中西药组合物 | |
CN101732664B (zh) | 含有恩前列素治疗胃溃疡的中西药组合物 | |
CN103405681B (zh) | 一种治疗口腔溃疡含片的制备方法 | |
CN101773646B (zh) | 一种含有丙谷胺的中西药组合物 | |
CN101721657B (zh) | 含有甘草锌的中西药组合物 | |
CN1088801A (zh) | 治疗顽痹、特别是ra和as的中成药金关片及其制法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |